查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1575127

体外诊断契约製造的市场规模、份额和趋势分析报告：按产品、服务、技术、最终用途、地区和细分市场预测，2024-2030 年

In Vitro Diagnostics Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Instruments, Software & Services), By Service, By Technology, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

体外诊断契约製造市场的成长与趋势：

Grand View Research, Inc.的最新报告显示，到2030年，全球体外诊断契约製造市场预计将达到374.5亿美元。

预计该市场在预测期内将以 10.04% 的复合年增长率成长。

由于对诊断设备的需求不断增长、照护现场诊断的普及、分子检测的进步以及慢性病患病率的增加，预计该市场将出现良好的成长潜力。此外，对具有成本效益的製造、技术创新和诊断方面严格监管合规性的需求不断增长，预计将增加市场收益。因此，医疗保健公司越来越倾向于将製造服务外包给 CMO 和 CDMO，以利用专业知识、简化生产并缩短上市时间，从而支持医疗保健行业的成长

体外诊断药物内部製造的高成本是推动市场成长的主要因素。开发和扩大体外诊断的生产需要在基础设施、专业设备、法规遵循和熟练劳动力方面进行大量资本投资，加速市场成长。这些管理费用会导致资源紧张，并降低中小型组织的盈利和灵活性。因此，透过将製造服务外包给 CMO 或 CDMO，公司可以降低製造成本并利用创新技术，而无需内部资本投资。此外，外包可以加快上市时间、提高扩充性和资源优化，进而提高体外诊断市场的竞争力。

此外，持续的技术进步是加速市场需求的主要因素之一，尤其是诊断设备和测试解决方案。分子诊断、次世代定序(NGS) 和自动化等技术创新正在提高体外诊断製造流程的准确性、速度和效率。这些进步正在帮助製造商满足对个人化医疗、照护现场诊断和更快的疾病检测方法日益增长的需求。此外，人工智慧主导技术和资料分析的整合优化了製造工作流程和品质保证流程，以提高准确性和对监管标准的合规性。此外，许多医疗保健公司正在寻求与契约製造製造商合作，以获取此类新技术，以加快上市时间、降低营运成本并提高产品的扩充性。因此，服务供应商对先进技术的整合预计将在未来几年推动市场成长。

报告体外诊断契约製造市场亮点

  • 从产品来看，试剂及耗材细分市场占据主导地位，2023年销售份额为69.34%。该领域的成长是由于对快速诊断解决方案和个人化医疗的需求不断增长。此外，对分子诊断和就地检验的日益偏好也增加了对专用试剂的需求。此外，自动化和次世代定序(NGS) 的不断进步进一步增加了对高品质耗材的需求。
  • 依服务业划分，2023年製造业服务业占最大。对快速、高品质诊断和个人化医疗保健解决方案的需求不断增长，推动了对扩大生产规模和扩大合约服务市场的需求。此外，对具有成本效益的生产和遵守严格监管标准的需求正在推动医疗保健公司将製造外包，以满足 IVD 市场不断增长的需求。
  • 按技术划分，免疫测量领域在 2023 年占据了最大的收益占有率。这一巨大的收益占有率归因于对准确、快速诊断测试的需求不断增长。此外，慢性病盛行率的增加和对个人化医疗的日益重视预计将推动该行业的成长。此外，生物标记发现的创新和照护现场诊断的扩展正在推动市场扩张。
  • 对先进和可自订诊断解决方案的需求不断增长，以及数位技术的整合以提高准确性，是加速该领域成长的关键因素。此外，严格的品质标准和服务供应商对创新技术的整合正在推动医疗设备製造商与提供创新能力和灵活解决方案的契约製造製造商伙伴关係，以满足不断增长的市场需求。
  • 2023 年，北美市场占据主导地位，份额为 41.91%。北美地区慢性病发病率的上升和对先进诊断解决方案的需求正在推动市场扩张。此外，对具有成本效益的製造解决方案的需求不断增长，正推动医疗保健公司外包体外诊断製造。诊断技术的监管支援和创新正在进一步推动市场势头，为受託製造领域的成长和合作创造机会。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 体外诊断契约製造市场的变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 技术景观
  • 产业生态系统分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第四章体外诊断契约製造市场：产品估算与趋势分析

  • 体外诊断契约製造市场（按产品）：细分仪表板
  • 体外诊断契约製造市场，依产品：波动分析
  • 按产品划分，2018-2030
  • 装置
  • 试剂/耗材
  • 软体和服务

第五章体外诊断契约製造市场：服务评估与趋势分析

  • 体外诊断契约製造市场（按服务）：细分仪表板
  • 体外诊断契约製造市场（按服务）：波动分析
  • 按服务划分，2018-2030
  • 製造服务
  • 检测开发服务
  • 其他服务

第六章体外诊断契约製造市场：技术评估与趋势分析

  • 体外诊断契约製造市场（按技术）：细分仪表板
  • 体外诊断契约製造市场（按技术）：波动分析
  • 按技术划分，2018-2030
  • 免疫检测
  • 临床化学
  • 分子诊断
  • 血液学
  • 微生物学
  • 凝固
  • 其他的

第七章 体外诊断契约製造市场：最终用途估计与趋势分析

  • 体外诊断契约製造市场，依最终用途：细分仪表板
  • 体外诊断契约製造市场（依最终用途）：波动分析
  • 按最终用途划分，2018-2030
  • 医疗设备公司
  • 学术/研究机构
  • 其他的

第八章体外诊断契约製造市场：区域估计和趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场简介
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 泰国
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 市场参与企业分类
    • 市场领导者
    • 新兴玩家
  • 2023 年企业市场占有率/估值分析
  • 2023 年服务热图分析
  • 公司简介
    • Jabil Inc.
    • Sanmina Corporation
    • TE Connectivity
    • Celestica Inc.
    • Savyon Diagnostics
    • West Pharmaceutical Services, Inc.
    • Thermo Fisher Scientific
    • KMC Systems
    • Cenogenics Corporation
    • Novo Biomedical
    • Cone Bioproducts
    • Invetech
    • AVIOQ Inc.
    • Meridian Bioscience Inc.
    • Nemera
Product Code: GVR-4-68040-462-6

In Vitro Diagnostics Contract Manufacturing Market Growth & Trends:

The global in vitro diagnostics contract manufacturing market size is expected to reach USD 37.45 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 10.04% over the forecast period.

The market is anticipated to witness lucrative growth potential owing to rising demand for diagnostic devices, an upsurge in point-of-care diagnostics, advancements in molecular testing, and the increasing prevalence of chronic diseases. Moreover, the growing need for cost-effective manufacturing, technological innovation, and stringent regulatory compliance for diagnostics is expected to drive the market revenue stream. Thus, the increasing trend for outsourcing manufacturing services to CMOs and CDMOs to access specialized expertise, streamline production, and accelerate time-to-market among healthcare companies is boosting overall market growth.

The high cost of in-house IVD manufacturing is a significant driver propelling the market growth. The need for high capital investment in infrastructure, specialized equipment, regulatory compliance, and skilled workforce to develop and scale up IVD production will accelerate market growth. These overhead costs strain resources, reducing profitability and flexibility among several small and medium-scale organizations. Thus, by outsourcing manufacturing services to CMOs & CDMOs, companies can lower manufacturing costs and gain access to innovative technologies exclusive of the need for internal capital investment. Moreover, outsourcing allows faster market entry, enhanced scalability, and better resource optimization and offers a competitive edge in the IVD market.

Furthermore, continuous technological advancements are among the major factors accelerating the market demand, specifically for diagnostic devices and testing solutions. Innovations such as molecular diagnostics, next-generation sequencing (NGS), and automation have enhanced the accuracy, speed, and efficiency of IVD manufacturing processes. These advancements assist manufacturers to meet the increasing demand for personalized medicine, point-of-care diagnostics, and faster disease detection methods. Moreover, the integration of AI-driven technologies and data analytics optimizes production workflows and quality assurance processes, enhancing precision and compliance with regulatory standards. Furthermore, numerous healthcare companies are involved in collaboration with contract manufacturers to access such novel technologies to accelerate time-to-market, reduce operational costs, and enhance product scalability. Thus, the integration of advanced technologies by service providers is estimated to drive market growth in the forthcoming years.

In Vitro Diagnostics Contract Manufacturing Market Report Highlights:

  • Based on product, the reagents & consumables segment dominated the market with a revenue share of 69.34% in 2023. The segment growth is attributed to increasing demand for rapid diagnostic solutions and personalized medicine. Moreover, increasing preference for molecular diagnostics and point-of-care testing are boosting the need for specialized reagents. In addition, continuous advances in automation and next-generation sequencing (NGS) are further bolstering the demand for high-quality consumables.
  • Based on service, the manufacturing services segment held the largest share in 2023. The increasing demand for rapid, high-quality diagnostics and personalized healthcare solutions spurs the demand for scale-up production, thereby expanding the contract services market. In addition, the need for cost-effective production and compliance with stringent regulatory standards drives healthcare companies to outsource manufacturing to meet the growing needs of the IVD market.
  • Based on technology, the immunoassay segment accounted for the largest revenue share in 2023. This large revenue share is owing to the rising demand for accurate and rapid diagnostic tests. Moreover, the increasing prevalence of chronic diseases and a growing emphasis on personalized medicine is anticipated to drive segmental growth. In addition, innovations in biomarker discovery and the expansion of point-of-care diagnostics are propelling market expansion.
  • Based on end use, the medical device companies segment accounted for the largest revenue share in 2023.Growing demand for advanced, customizable diagnostic solutions and the integration of digital technologies for enhanced accuracy are key factors accelerating segment growth. Moreover, stringent quality standards and the integration of innovative technologies by service providers are major factors accelerating collaboration and partnerships by medical device companies with contract manufacturers that offer innovative capabilities and flexible solutions to meet growing market needs.
  • North America dominated the market with a share of 41.91% in 2023. The increasing prevalence of chronic diseases and the demand for advanced diagnostic solutions in the North American region are propelling market expansion. In addition, the rising need for cost-effective manufacturing solutions is leading healthcare companies to outsource IVD production. Regulatory support and innovation in diagnostic technologies further drive market momentum, creating opportunities for growth and collaboration within the contract manufacturing sector.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates And Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. In Vitro Diagnostics Contract Manufacturing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technology Landscape
  • 3.4. Industry Ecosystem Analysis
  • 3.5. Industry Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. In Vitro Diagnostics (Contract Manufacturing Market: Phases Estimates & Trend Analysis

  • 4.1. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Product: Segment Dashboard
  • 4.2. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Product: Movement Analysis
  • 4.3. In Vitro Diagnostics (IVD) Contract Manufacturing Market Estimates & Forecasts, By Product, 2018 - 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments Market, 2018 to 2030 (USD Million)
  • 4.5. Reagents & Consumables
    • 4.5.1. Reagents & Consumables Market, 2018 to 2030 (USD Million)
  • 4.6. Software & Services
    • 4.6.1. Software & Services Market, 2018 to 2030 (USD Million)

Chapter 5. In Vitro Diagnostics Contract Manufacturing Market: Service Estimates & Trend Analysis

  • 5.1. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Service: Segment Dashboard
  • 5.2. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Service: Movement Analysis
  • 5.3. In Vitro Diagnostics (IVD) Contract Manufacturing Market Estimates & Forecasts, By Service, 2018 - 2030 (USD Million)
  • 5.4. Manufacturing Services
    • 5.4.1. Manufacturing Services Market, 2018 to 2030 (USD Million)
  • 5.5. Assay Development Services
    • 5.5.1. Assay Development Services Market, 2018 to 2030 (USD Million)
  • 5.6. Other Services
    • 5.6.1. Other Services Market, 2018 to 2030 (USD Million)

Chapter 6. In Vitro Diagnostics Contract Manufacturing Market: Technology Estimates & Trend Analysis

  • 6.1. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Technology: Segment Dashboard
  • 6.2. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Technology: Movement Analysis
  • 6.3. In Vitro Diagnostics (IVD) Contract Manufacturing Market Estimates & Forecasts, By Technology, 2018-2030
  • 6.4. Immunoassays
    • 6.4.1. Immunoassays Market, 2018 to 2030 (USD Million)
  • 6.5. Clinical Chemistry
    • 6.5.1. Clinical Chemistry Market, 2018 to 2030 (USD Million)
  • 6.6. Molecular Diagnostics
    • 6.6.1. Molecular Diagnostics Market, 2018 to 2030 (USD Million)
  • 6.7. Hematology
    • 6.7.1. Hematology Market, 2018 to 2030 (USD Million)
  • 6.8. Microbiology
    • 6.8.1. Microbiology Market, 2018 to 2030 (USD Million)
  • 6.9. Coagulation
    • 6.9.1. Coagulation Market, 2018 to 2030 (USD Million)
  • 6.10. Others
    • 6.10.1. Others Market, 2018 to 2030 (USD Million)

Chapter 7. In Vitro Diagnostics Contract Manufacturing Market: End Use Estimates & Trend Analysis

  • 7.1. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By End Use: Segment Dashboard
  • 7.2. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By End Use: Movement Analysis
  • 7.3. In Vitro Diagnostics (IVD) Contract Manufacturing Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
  • 7.4. Medical Device Companies
    • 7.4.1. Medical Device Companies Market, 2018 to 2030 (USD Million)
  • 7.5. Academic & Research Institutions
    • 7.5.1. Academic & Research Institutions Market, 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market, 2018 to 2030 (USD Million)

Chapter 8. In Vitro Diagnostics Contract Manufacturing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. North America
    • 8.4.1. Market Estimates and Forecast, 2018-2030 (Revenue, USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Market Estimates and Forecast, 2018-2030 (Revenue, USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Market Estimates and Forecast, 2018-2030 (Revenue, USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Thailand
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Australia
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Market Estimates and Forecast, 2018-2030 (Revenue, USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. Market Estimates and Forecast, 2018-2030 (Revenue, USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
    • 9.1.1. Market Leaders
    • 9.1.2. Emerging Players
  • 9.2. Company Market Share/Assessment Analysis, 2023
  • 9.3. Service Heat Map Analysis, 2023
  • 9.4. Company Profiles
    • 9.4.1. Jabil Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Service Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Sanmina Corporation
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Service Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. TE Connectivity
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Service Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Celestica Inc.
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Service Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Savyon Diagnostics
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Service Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. West Pharmaceutical Services, Inc.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Service Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Thermo Fisher Scientific
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Service Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. KMC Systems
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Service Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Cenogenics Corporation
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Service Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Novo Biomedical
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Service Benchmarking
      • 9.4.10.4. Strategic Initiatives
    • 9.4.11. Cone Bioproducts
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Financial Performance
      • 9.4.11.3. Service Benchmarking
      • 9.4.11.4. Strategic Initiatives
    • 9.4.12. Invetech
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Financial Performance
      • 9.4.12.3. Service Benchmarking
      • 9.4.12.4. Strategic Initiatives
    • 9.4.13. AVIOQ Inc.
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Financial Performance
      • 9.4.13.3. Service Benchmarking
      • 9.4.13.4. Strategic Initiatives
    • 9.4.14. Meridian Bioscience Inc.
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Financial Performance
      • 9.4.14.3. Service Benchmarking
      • 9.4.14.4. Strategic Initiatives
    • 9.4.15. Nemera
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Financial Performance
      • 9.4.15.3. Service Benchmarking
      • 9.4.15.4. Strategic Initiatives

List of Tables

  • Table. 1 Market segmentation
  • Table. 2 Market research process
  • Table. 3 Information procurement
  • Table. 4 Primary research pattern
  • Table. 5 Market research approaches
  • Table. 6 Value chain-based sizing & forecasting
  • Table. 7 QFD modelling for market share assessment
  • Table. 8 Market formulation & validation
  • Table. 9 In Vitro Diagnostics (IVD) contract manufacturing market revenue, 2018 - 2030 (USD Million)
  • Table. 10 In Vitro Diagnostics (IVD) contract manufacturing market snapshot
  • Table. 11 In Vitro Diagnostics (IVD) contract manufacturing market driver impact
  • Table. 12 In Vitro Diagnostics (IVD) contract manufacturing market restraint impact
  • Table. 13 In Vitro Diagnostics (IVD) contract manufacturing sector key takeaways (USD Million)
  • Table. 14 In Vitro Diagnostics (IVD) contract manufacturing Market: Product movement analysis
  • Table. 15 Instruments market, 2018 - 2030 (USD Million)
  • Table. 16 Reagents & consumables market, 2018 - 2030 (USD Million)
  • Table. 17 Software & services market, 2018 - 2030 (USD Million)
  • Table. 18 In Vitro Diagnostics (IVD) contract manufacturing market service key takeaways (USD Million)
  • Table. 19 In Vitro Diagnostics (IVD) contract manufacturing market: service movement analysis
  • Table. 20 Manufacturing services market, 2018 - 2030 (USD Million)
  • Table. 21 Assay development services market, 2018 - 2030 (USD Million)
  • Table. 22 Other services market, 2018 - 2030 (USD Million)
  • Table. 23 In Vitro Diagnostics (IVD) contract manufacturing market technology key takeaways (USD Million)
  • Table. 24 In Vitro Diagnostics (IVD) contract manufacturing market: technology movement analysis
  • Table. 25 Immunoassays market, 2018 - 2030 (USD Million)
  • Table. 26 Clinical chemistry market, 2018 - 2030 (USD Million)
  • Table. 27 Molecular diagnostics market, 2018 - 2030 (USD Million)
  • Table. 28 Hematology market, 2018 - 2030 (USD Million)
  • Table. 29 Microbiology market, 2018 - 2030 (USD Million)
  • Table. 30 Coagulation market, 2018 - 2030 (USD Million)
  • Table. 31 Others market, 2018 - 2030 (USD Million)
  • Table. 32 In Vitro Diagnostics (IVD) contract manufacturing market end use key takeaways (USD Million)
  • Table. 33 In Vitro Diagnostics (IVD) contract manufacturing market: end use movement analysis
  • Table. 34 Medical device companies' market, 2018 - 2030 (USD Million)
  • Table. 35 Academic & research institutions market, 2018 - 2030 (USD Million)
  • Table. 36 Others market, 2018 - 2030 (USD Million)
  • Table. 37 Regional marketplace: Key takeaways
  • Table. 38 Regional outlook, 2023 & 2030
  • Table. 39 North America In Vitro Diagnostics (IVD) contract manufacturing Market, 2018 - 2030 (USD Million)
  • Table. 40 U.S. In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 41 Canada In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 42 Mexico In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 43 Europe In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 44 UK In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 45 Germany In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 46 France In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 47 Italy In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 48 Spain companion animal Health market, 2018 - 2030 (USD Million)
  • Table. 49 Sweden In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 50 Denmark In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 51 Norway In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 52 Asia Pacific In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 53 Japan In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 54 China In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 55 India In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 56 Thailand In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 57 South Korea In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 58 Australia In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 59 Latin America In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 60 Brazil In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 61 Argentina In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 62 Middle East & Africa In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 63 South Africa In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 64 Saudi Arabia In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 65 UAE In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 66 Kuwait In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 67 Market participant categorization

List of Figures

  • Fig. 1 List of Tables
  • Fig. 2 List of Secondary Sources
  • Fig. 3 List of Abbreviations
  • Fig. 4 Global In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 5 Global In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 6 Global In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 7 Global In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 8 Global In Vitro Diagnostics (IVD) Contract Manufacturing, by Region, 2018 - 2030 (USD Million)
  • Fig. 9 North America In Vitro Diagnostics (IVD) Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 10 North America In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 11 North America In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 12 North America In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 13 North America In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 14 U.S. In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 15 U.S. In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 16 U.S. In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 17 U.S. In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 18 Canada In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 19 Canada In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 20 Canada In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 21 Canada In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 22 Mexico In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 23 Mexico In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 24 Mexico In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 25 Mexico In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 26 Europe In Vitro Diagnostics (IVD) Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 27 Europe In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 28 Europe In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 29 Europe In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 30 Europe In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 31 Germany In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 32 Germany In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 33 Germany In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 34 Germany In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 35 UK In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 36 UK In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 37 UK In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 38 UK In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 39 France In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 40 France In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 41 France In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 42 France In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 43 Italy In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 44 Italy In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 45 Italy In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 46 Italy In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 47 Spain In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 48 Spain In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 49 Spain In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 50 Spain In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 52 Denmark In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 56 Sweden In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 57 Sweden In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 58 Sweden In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 59 Norway In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 60 Norway In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 61 Norway In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 62 Norway In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 63 Asia Pacific In Vitro Diagnostics (IVD) Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 64 Asia Pacific In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 65 Asia Pacific In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 66 Asia Pacific In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 67 Asia Pacific In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 68 China In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 69 China In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 70 China In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 71 China In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 72 Japan In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 73 Japan In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 74 Japan In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 75 Japan In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 76 India In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 77 India In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 78 India In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 79 India In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 80 South Korea In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 81 South Korea In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 82 South Korea In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 83 South Korea In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 84 Australia In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 85 Australia In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 86 Australia In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 87 Australia In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 88 Thailand In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 89 Thailand In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 90 Thailand In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 91 Thailand In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 92 Latin America In Vitro Diagnostics (IVD) Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 93 Latin America In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 94 Latin America In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 95 Latin America In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 96 Latin America In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 97 Brazil In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 98 Brazil In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 99 Brazil In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 100 Brazil In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 101 Argentina In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 102 Argentina In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 103 Argentina In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 104 Argentina In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 105 Middle East & Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 106 Middle East & Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 107 Middle East & Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 108 Middle East & Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 109 Middle East & Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 110 South Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 111 South Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 112 South Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 113 South Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 114 Saudi Arabia In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 115 Saudi Arabia In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 116 Saudi Arabia In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 117 Saudi Arabia In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 118 UAE In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 119 UAE In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 120 UAE In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 121 UAE In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 122 Kuwait In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 123 Kuwait In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 124 Kuwait In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 125 Kuwait In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)